Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Re: "First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants".

Palmu AA, Lahdenkari M.

Pediatr Infect Dis J. 2018 Dec;37(12):e352-e353. doi: 10.1097/INF.0000000000002036. No abstract available.

PMID:
30408014
2.
3.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
4.

Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life.

Vaarala O, Jokinen J, Lahdenkari M, Leino T.

Pediatr Infect Dis J. 2017 Jul;36(7):674-675. doi: 10.1097/INF.0000000000001600.

PMID:
28399059
5.

Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.

Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.

J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9.

PMID:
26908733
6.

Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.

Syrjänen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, Kilpi TM.

PLoS One. 2014 Sep 29;9(9):e108538. doi: 10.1371/journal.pone.0108538. eCollection 2014.

7.

Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.

Sarasoja I, Jokinen J, Lahdenkari M, Kilpi T, Palmu AA.

Pediatr Infect Dis J. 2013 May;32(5):517-20. doi: 10.1097/INF.0b013e31827c9bcc.

PMID:
23190780
8.

Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Lahdenkari M, Givon-Lavi N, Käyhty H, Dagan R, Jokinen J.

Clin Vaccine Immunol. 2012 Jan;19(1):96-9. doi: 10.1128/CVI.05369-11. Epub 2011 Nov 9.

9.

Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children.

Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Käyhty H.

Vaccine. 2009 Jul 23;27(34):4615-21. doi: 10.1016/j.vaccine.2009.05.071. Epub 2009 Jun 12.

PMID:
19524618
10.

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Melin MM, Hollingshead SK, Briles DE, Lahdenkari MI, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1529-35. doi: 10.1128/CVI.00181-08. Epub 2008 Aug 27.

11.

Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1555-63. doi: 10.1128/CVI.00177-08. Epub 2008 Aug 27.

12.

Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins.

Simell B, Lahdenkari M, Reunanen A, Käyhty H, Väkeväinen M.

Clin Vaccine Immunol. 2008 Sep;15(9):1391-7. doi: 10.1128/CVI.00110-08. Epub 2008 Jul 2.

13.

Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.

Simell B, Melin M, Lahdenkari M, Briles DE, Hollingshead SK, Kilpi TM, Kayhty H.

J Infect Dis. 2007 Nov 15;196(10):1528-36. Epub 2007 Oct 31. Erratum in: J Infect Dis. 2008 Mar 1;197(5):779-80.

PMID:
18008233
14.

Serum antibodies to the pneumococcal surface proteins PhtB and PhtE in Finnish infants and adults.

Holmlund E, Simell B, Jaakkola T, Lahdenkari M, Hamel J, Brodeur B, Kilpi T, Käyhty H.

Pediatr Infect Dis J. 2007 May;26(5):447-9.

PMID:
17468659
15.

A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.

Parkkali T, Käyhty H, Hovi T, Olander RM, Roivainen M, Volin L, Ruutu T, Lahdenkari M, Ruutu P.

Bone Marrow Transplant. 2007 Feb;39(3):179-88. Epub 2007 Jan 8.

PMID:
17211432
16.

Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.

Simell B, Jaakkola T, Lahdenkari M, Briles D, Hollingshead S, Kilpi TM, Käyhty H.

Clin Vaccine Immunol. 2006 Oct;13(10):1177-9. Epub 2006 Aug 23.

17.

Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media.

Bogaert D, Holmlund E, Lahdenkari M, de Groot R, Kilpi T, Hermans PW, Kayhty H.

FEMS Immunol Med Microbiol. 2006 Mar;46(2):166-8.

18.

Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children?

Kleemola M, Nokso-Koivisto J, Herva E, Syrjänen R, Lahdenkari M, Kilpi T, Hovi T.

J Infect. 2006 Mar;52(3):181-7. Epub 2005 Jun 29.

PMID:
15992930
19.

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu AA, Käyhty H; FinOM Study Group.

BMC Infect Dis. 2005 May 27;5:41.

20.

Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu A, Käyhty H; FinOM Study Group.

Vaccine. 2004 Dec 2;23(3):298-304.

PMID:
15530671
21.
22.

Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media?

Palmu AA, Saukkoriipi PA, Lahdenkari MI, Kuisma LK, Makela PH, Kilpi TM, Leinonen M.

J Infect Dis. 2004 Mar 1;189(5):775-84. Epub 2004 Feb 16.

PMID:
14976593
23.

Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media.

Soininen A, Lahdenkari M, Kilpi T, Mäkelä PH, Käyhty H.

Pediatr Infect Dis J. 2002 Mar;21(3):186-92.

PMID:
12005079
24.

Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?

Rapola S, Kilpi T, Lahdenkari M, Takala AK, Mäkelä PH, Käyhty H.

J Infect Dis. 2001 Sep 1;184(5):577-81. Epub 2001 Jul 30.

PMID:
11494164
25.

Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media.

Rapola S, Kilpi T, Lahdenkari M, Mäkelä PH, Käyhty H.

Pediatr Infect Dis J. 2001 May;20(5):482-7.

PMID:
11368104

Supplemental Content

Loading ...
Support Center